Content-Type: |
text/plain; charset="us-ascii" |
Date: |
Tue, 26 Nov 2019 07:28:19 +0000 |
Reply-To: |
|
Subject: |
|
MIME-Version: |
1.0 |
Message-ID: |
|
Content-Transfer-Encoding: |
quoted-printable |
Sender: |
|
From: |
|
Parts/Attachments: |
|
|
Hi there,
Our user is looking for this article. Could you render help?
Source: Journal of Endocrinological Investigation vol. 38(2) p. 177-82, 2015
Title: Prospectively recorded and MedRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.
Thank you very much in advance.
Angela Wong
Librarian
New Territories West Cluster
Hospital Authority
Hong Kong
________________________________
***************************************************************************
Disclaimer
This Email may contain privileged and confidential information and is solely for the use of the intended recipient. If you are not the intended recipient, you must not print, copy, distribute or take any action in reliance on it. If you have received this Email by mistake, please notify the sender and then delete this Email from your computer. The Hospital Authority does not accept liability arising from Email transmitted by mistake.
Although this Email and any attachments are believed to be free of virus or other defects that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free, and no responsibility is accepted by the Hospital Authority for any loss or damage in any way arising from its use.
All views or opinions expressed in this Email and its attachments are those of the sender and do not necessarily reflect the views and opinions of the Hospital Authority.
***************************************************************************
|
|
|